Basement membranes, microfibrils and β amyloid fibrillogenesis in Alzheimer's disease: High resolution ultrastructural findings

Brain Research Reviews

Volumn 29, Issue 2-3, 1999, Pages 218-231

  Inoue, Sadayuki ^a   Kuroiwa, Mie ^a   Kisilevsky, Robert ^b  

^a MCGILL UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

amyloid fibril; Alzheimer's disease; Basement membrane; Microfibril; Ultrastructure

Indexed keywords

AMYLOID BETA PROTEIN; BETA 2 MICROGLOBULIN;

ALZHEIMER DISEASE; BASEMENT MEMBRANE; BIOACCUMULATION; CELL ULTRASTRUCTURE; HUMAN; IMMUNOHISTOCHEMISTRY; MICROFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; BASEMENT MEMBRANE; HUMANS; NEUROFIBRILS;

EID: 0032927687     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(98)00055-1     Document Type: Review

References (94)

1. Burdick D., Soreghan B., Kwon M., Kosmoski J., Knauer M., Henschen A., Yates J., Cotman C., Glabe C. Assembly and aggregational properties of syntheic Alzheimer's A4/β amyloid peptide analogs. J. Biol. Chem. 267:1992;546-554.
2. Carlson E.C., Upson R.H., Evans D.K. The production of extracellular connective tissue fibrils by chick notochordal epithelium in vitro. Anat. Rec. 179:1974;361-375.
3. Carrie B.J., Meyers B.D. Proteinuria and the functional characteristics of the glomerular barrier in diabetic nephropathy. Kidney Int. 17:1980;669-676.
4. Castaño E.M., Frangione B. Human amyloidosis, Alzheimer's disease and related disorders. Lab. Invest. 58:1988;122-132.
5. Castaño E.M., Prelli F., Wisniewski T., Golabek A., Kumar R.A., Soto C., Frangione B. Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E. Biochem. J. 306:1995;599-604.
6. Cleary E.G., Gibson M.A. Elastin-associated microfibrils and microfibrillar proteins. Int. Rev. Connect. Tiss. Res. 10:1983;97-209.
7. Corsellis J.A.N., Brierley J.B. An unusual type of presenile dementia. Brain. 77:1954;571-587.
8. Cossel L., Lisewski G., Mohnike G. Elektronenmikroskopische und klinische untersuchungen bei diabetischer glomerulosklerose. Klin. Wochenschr. 37:1959;1005-1018.
9. Churg J., Dachs S. Diabetic renal disease: arteriosclerosis and glomerulosclerosis. Pathol. Annu. 1:1966;148-171.
10. Dewitt D.A., Silver J., Canning D.R., Perry G. Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease. Exp. Neurol. 121:1993;149-152.
11. M.G. Farquhar, Fine structure of normal and diabetic glomerular capillaries, in: S.J. Kumura, M. Caygill (Eds.), Vascular Complications in Diabetes Mellitus, The CV Mosby Company, St. Louis, 1967, pp. 99-113.
12. M.G. Farquhar, Structure and function of glomerular caapillaries, in: N.A. Kefalides (Ed.), Biology and Chemistry of Basement Membranes, Academic Press, New York, 1978, pp. 43-80.
13. Farquhar M.G., Wissig S.L., Palade G.E. Glomerular permeability: I. Ferritin transfer across the normal glomerular capillary wall. J. Exp. Med. 113:1961;47-66.
14. Friedman J., Jones H.W. III, Golbetz H.V., Lee J.A., Little H.L., Meyers B.D. Mechanisms of proteinuria in diabetetic nephropathy: II. A study of the size-selective glomerular filtration barrier. Diabetes. 32:1983;40-46. Suppl 2.
15. Fujiwara S., Wiedeman H., Timpl A., Lustig A., Engel J. Structure and interactions of heparan sulfate proteoglycan from a mouse tumor basement membrane. Eur. J. Biochem. 143:1984;145-157.
16. Glenner G.G., Wong C.W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120:1984;885-890.
17. Hassell J.R., Kimura J.H., Hascall V.C. Proteoglycan core protein families. Annu. Rev. Biochem. 55:1986;539-567.
18. Hassell J.R., Leyshon W.C., Ledbetter S.R., Tyree B., Suzuki S., Kato M., Kimata K., Kleinman H.K. Isolation of two forms of basement membrane proteoglycans. J. Biol. Chem. 260:1985;8098-8105.
19. Hassell J.R., Robey P.G., Barrach H.J., Wilczek J., Rennard S.I., Martin G.R. Isolaion of heparan sulfate-containing proteoglycan from basement membrane. Proc. Natl. Acad. Sci. USA. 77:1980;4494-4498.
20. Hassler O. Vascular changes in senile brains: a micro-angiographic study. Acta Neuropathol. (Berl.). 5:1965;40-53.
21. Haust H.D. Fine fibrils of extracellular space (microfilaments): their structure and role in connective tissue organization. Am. J. Pathol. 47:1965;1113-1137.
22. Hedman K., Johansson S., Uartio T., Kjellen L., Vaheri A., Höök M. Structure of the pericellular matrix: association of heparan and chondroitin sulfate with fibronectin-proteoglycan fibers. Cell. 28:1982;663-671.
23. Hsu H.-C., Churg J. Glomerular microfibrils in renal disease: a comparative electron microscopy study. Kidney Int. 16:1979;497-504.
24. Inoue S. Ultrastructure of basement membranes. Int. Rev. Cytol. 117:1989;57-98.
25. Inoue S. Pentosome - a new connective tissue component - is a subunit of amyloid P. Cell Tiss. Res. 263:1991;431-438.
26. Inoue S. Basic structure of basement membranes is a fine network of 'cords, irregular anastomosing strands. Microsc. Res. Tech. 28:1994;29-47.
27. S. Inoue, Ultrastructural architecture of basement membranes, in: H. Koide, T. Hayashi (Eds.), Extracellular Matrix in the Kidney. Contrib. Nephrol., Vol. 107, Karger, Basel, 1994b, pp. 21-28.
28. Inoue S. Ultrastructural organization of connective tissue mirofibrils in the posterior chamber of the eye in vivo and in vitro. Cell Tiss. Res. 279:1995;291-302.
29. Inoue S. Ultrastructural and immunohistochemical studies of microfibril-associated components in the posterior chamber of the eye. Cell Tiss. Res. 279:1995;303-313.
30. S. Inoue, Application of high resolution electron microscopy to the study of basement membranes: recent advances, in: M. Motta (Ed.), Recent Advances in Microscopy of Cells, Tissues and Organs, Antonio Delfino Editore, Rome, 1997, pp. 141-147.
31. Inoue S., Bendayan M. High-resolution ultrastructural study of the rat glomerular basement membrane in long-term experimental diabetes. Ultrastruct. Pathol. 19:1995;175-185.
32. Inoue S., Kisilevsky R. A high resolution ultrastructural study of experimental murine AA amyloid. Lab. Invest. 74:1996;670-683.
33. Inoue S., Leblond C.P. The basement-membrane-like matrix of the mouse EHS tumor: I. Ultrastructure. Am. J. Anat. 174:1985;373-386.
34. Inoue S., Leblond C.P. The microfibrils of connective tissue: I. ultrastructure. Am. J. Anat. 176:1986;121-138.
35. Inoue S., Grant D., Leblond C.P. Heparan sulfate proteoglycan is present in basement membrane as a double-tracked structure. J. Histochem. Cytochem. 37:1989;597-602.
36. Inoue S., Kuroiwa M., Ohashi K., Hara M., Kisilevsky R. Ultrastructural organization of hemodialysis-associated β2-microglobulin amyloid fibrils. Kidney Int. 52:1997;1543-1549.
37. Inoue S., Kuroiwa M., Tan R., Kisilevsky R. A high resolution ultrastructural comparison of isolated and in-situ murine AA amyloid fibrils. Amyloid Int. J. Exp. Clin. Invest. 5:1998;99-110.
38. Inoue S., Leblond C.P., Laurie G.W. Ultrastructure of Reichert's membrane, a multilayered basement membrane in the parietal wall of the rat yolk sac. J. Cell Biol. 97:1983;1524-1537.
39. Inoue S., Leblond C.P., Rico P., Grant D. Association of fibronectin with the microfibrils of connective tissue. Am. J. Anat. 186:1989;43-54.
40. Inoue S., Skinner M., Leblond C.P., Shirahama T., Cohen A.S. Isolation of the amyloid P component from the Engelbreth-Holm-Swarm (EHS) tumor of the mouse. Biochem. Biophys. Res. Commun. 134:1986;995-999.
41. Inouye H., Fraser P.E., Kirschner D.A. Structure of β-crystallite assemblies formed by Alzheimer's β-amyloid protein analogues: analysis by X-ray diffraction. Biophys. J. 64:1993;502-519.
42. Iozzo R.V., Clark C.C. Biosynthesis of proteoglycans by rat embryo parietal yolk sac in organ culture. J. Biol. Chem. 261:1986;6658-6669.
43. Ishii T. Enzyme histochemical studies of senile plaques and the plaque-like degeneration of arteries and capillaries. Acta Neuropathol. (Berl.). 14:1969;250-260.
44. Kirschner D.A., Abraham C., Selkoe D.J. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibrils in Alzheimer's disease indicates cross-β conformation. Proc. Natl. Acad. Sci. USA. 83:1986;503-507.
45. Kisilevsky R., Fraser P.E. Aβ amyloidogenesis: unique or variation on a systemic theme? Crit. Rev. Biochem. Mol. Biol. 32:1997;361-404.
46. Koda J.E., Bernfield M. Heparan sulfate proteoglycans from mouse mammary epithelial cells: basal extracellular proteoglycan binds specifically to native type I collagen fibrils. J. Biol. Chem. 259:1984;11763-11770.
47. Latta H. The glomerular capillary wall. J. Ultrastruct. Res. 32:1970;526-544.
48. Laurie G.W. Lack of heparan sulfate proteoglycan in a discontinuous and irregular placental basement membrane. Dev. Biol. 108:1985;299-309.
49. Laurie G.W., Leblond C.P., Inoue S., Martin G.R., Chung A. Fine structure of the glomerular basement membrane and immunolocalization five basement membrane components to the lamina densa (basal lamina) and its extensions in both glomeruli and tubules of the rat kidney. Am. J. Anat. 169:1984;463-481.
50. Lin W.-L., Essner E., McCarthy K.J., Couchman J.R. Ultrastructural immunocytochemical localization of chondroitin sulfate proteoglycan in Bruch's membrane of the rat. Invest. Ophthalmol. Vis. Sci. 33:1992;2072-2075.
51. Low F.N. The extracellular portion of the human blood-air barrier and its relation to tissue space. Anat. Rec. 139:1961;105-124.
52. Low F.N. Microfibrils, fine filamentous components of the tissue space. Anat. Rec. 142:1962;131-137.
53. Mancardi G.L., Perdelli F., Rivano C., Leonardi A., Bugiani O. Thickening of the basement membrane of cortical capillaries in Alzheimer's disease. Acta Neuropathol. (Berl.). 49:1980;79-83.
54. McCarthy K.J., Accavite M.A., Couchman J.R. Immunological characterization of a basement membrane-specific chondroitin sulfate proteoglycan. J. Cell Biol. 109:1989;3187-3198.
55. McCarthy K.J., Couchman J.R. Basement membrane chondroitin sulfate proteoglycans: localization in adult rat tissues. J. Histochem. Cytochem. 38:1990;1479-1486.
56. McCarthy K.J., Horiguchi Y., Couchman J.R., Fine J.-D. Ultrastructural localization of the core protein of a basement membrane-specific chondroitin sulfate proteoglycan in adult rat skin. Arch. Dermatol. Res. 282:1990;397-401.
57. Merz P.A., Wisniewski H.M., Somerville R.A., Bobin S.A., Masters C.L., Iqbal K. Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques. Acta Neuropathol. 60:1983;113-124.
58. Miyakawa T., Uehara Y. Observations of amyloid angiopathy and senile plaques by the scanning electron microscope. Acta Neuropathol. 48:1979;153-156.
59. Miyakawa T., Sumiyoshi S., Murayama E., Deshimaru M. Ultrastructure of capillary plaque-like degeneration in senile dementia. Mechanism of amyloid production. Acta Neuropathol. 29:1974;229-236.
60. Miyakawa T., Shimoji A., Kuramoto R., Higuchi Y. The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Virchows Arch. [Cell Pathol.]. 40:1982;121-129.
61. Miyakawa T., Katsuragi S., Watanabe K., Shimoji A., Ikeuchi Y. Ultrastructural studies of amyloid fibrils and senile plaques in human brain. Acta neuropathol. (Berl.). 70:1986;202-208.
62. Miyakawa T., Watanabe K., Katsuragi S. Ultrastructure of amyloid fibrils in Alzheimer's disease and Down's syndrome. Virchows Arch. [Cell Pathol.]. 52:1986;99-106.
63. Miyakawa T., Katsuragi S., Kuramoto R. Ultrastructure of perivascular amyloid fibrils in Alzheimer's disease. Virchows Arch. [Cell Pathol.]. 56:1988;21-24.
64. T. Miyakawa, S. Katsuragi, K. Watanabe, in: T. Isobe, S. Araki, F. Uchino, S. Kato, E. Tsubura, (Eds.) Amyloid and Amyloidosis, Proceedings of 5th International Symposium on amyloidosis, Hakone, Japan. Plenum, New York, 1990, pp. 573-578.
65. Morgensen C.E., Østerby R., Gundersen H.J.G. Early functional and morphologic vascular renal consequences of the diabetic state. Diabetologia. 17:1979;71-76.
66. Namba Y., Tomonaga M., Kawasaki H., Otomo E., Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jacob disease. Brain Res. 541:1991;163-166.
67. S. Narindrasorasak, I. Young, S. Aubin, S.K. Ludwin, R. Kisilevsky, Basement membrane heparan sulfate proteoglycan is part of isolated Alzheimer's amyloid plaques, in: K. Iqbal, D.R.C. McLahlan, B. Winblad andH.M. Wisniewski, (Eds.), Alzheimer's Disease, Basic Mechanisms, Diagnosis and Therapeutic, Wiley, New York, 1991, pp. 289-296.
68. Østerby R. Early phases in the development of diabetic glomerulopathy: a quantitative electron microscope study. Acta Med. Scand. 574(Suppl.):1974;1-82.
69. Perlmutter L.S., Athanikar J., Zarow C., Chui H.C. Basement membrane pathology in dementia. Soc. Neurosci. Abstr. 14:1988;639.
70. Perlmutter L.S., Barron E., Saperia D., Chui H.C. Association between vascular basement membrane components and the lesions of Alzheimer's disease. J. Neurosci. Res. 30:1991;673-681.
71. Perlmutter L.S., Chui H.C. Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review. Brain Res. Bull. 24:1990;677-686.
72. Roher A.E., Palmer K.C., Yurewicz E.C., Ball M.J., Greenberg B.D. Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer's disease tissue. J Neurochem. 61:1993;1916-1926.
73. Saunders A.M., Strittmatter W.J., Schmechel D. Association of apolipoprotein E allele ε4 with late-onset and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
74. Sawada T., Inoue S. Characterization of the fibrillar layer at the epithelial-mesenchymal junction in tooth germs. Cell Tiss. Res. 278:1994;563-571.
75. Sawada T., Inoue S. High resolution ultrastructural study of resorption of elastic fibers by fibroblasts in monkey gingiva. Mol. Biol. Cell. 8:1997;66a. (Abstr.).
76. A.B. Scheibel, Changes in brain capillary structure in aging and dementia, in: J. Wertheimer, M. Marois, (Eds.), Senile Dementia, Outlook for the Future, Alan R. Liss, New York, 1984, pp. 137-149.
77. Scheibel A.B., Duong T., Tomiyasu U. Denervation microangiopathy in senile dementia, Alzheimer type. Alzheimer Dis. Assoc. Discord. 1:1987;19-37.
78. Schneeberger-Keeley E.E., Karnovsky M.J. The ultrastructural basis of alveolar-capillary membrane permeability to peroxidase used as a tracer. J. Cell Biol. 37:1968;781-793.
79. Schneeberger E.E., Karnovsky M.L. The intravascular fluid volume on the permeability of newborn and adult mouse lungs to ultrastructural protein tracers. J. Cell Biol. 49:1971;319-334.
80. Scholz W. Studien zur Pathologie der Hirngefässe: II. Die drüsige Entartung der Hirnarterien und Capillaren. Z. Neurol. 162:1938;694-715.
81. Snow A.D., Wight T.N. Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses. Neurobiol. Aging. 10:1989;481-497.
82. Snow A.D., Mar H., Nochlin D., Kimata K., Kato M., Suzuki S., Hassell J., Wight T.N. The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133:1988;456-463.
83. Snow A.D., Lara S., Nochlin D., Wight T.N. Cationic dyes reveal proteoglycans structurally integrated within the characteristic lesions of Alzheimer's disease. Acta Neuropathol. 78:1989;113-123.
84. Snow A.D., Mar H., Nochlin D., Kresse H., Wight T.N. Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence of neurofibrillary tangles of Alzheimer's disease. J. Histochem. Cytochem. 40:1992;105-113.
85. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S., Roses A.D. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 90:1993;1977-1981.
86. Terry R.D., Gonatas N.K., Weiss M. Ultrastructural studies in Alzheimer's presenile dementia. Am. J. Pathol. 44:1964;269-297.
87. van Duijn C.M., Deknijff P., Cruts M., Wehnert A., Havekes L.M., Hofman A., van Broeckhoven C. Apolipoprotein ε4 allele in a population-based study of early onset Alzheimer's disease. Nature Genet. 7:1994;74-78.
88. Viberti G., MacKintosh D., Bilous R.W., Pickup J.C., Keen H. Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia. Kidney Int. 21:1982;714-720.
89. Wisniewski T., Frangione B. Apolipoprotein E: a pathological chaperone protein in patients witth cerebral and systemic amyloid. Neurosci. Lett. 135:1992;235-238.
90. H.M. Wisniewski, R.D. Terry, Reexamination of the pathogenesis of the senile plaque, in: H.M. Zimmerman, (Ed.), Progress in Neuropathology, Vol. 11, Grune and Stratton, New York, 1973, pp. 1-26.
91. Wisniewski H.M., Johnson A.B., Raine C.S., Kay W.J., Terry R.D. Senile plaque and cerebral amyloidosis in aged dogs: a histochemical and ultrastructural study. Lab. Invest. 23:1970;287-296.
92. Wong C.W., Quavanta V., Glenner G.G. Neuritic plaques and cerebrovascular amyloid in Alzheimer's disease are antigenically related. Proc. Natl. Acad. Sci. USA. 82:1985;8729-8732.
93. Young I.D., Willmer J.P., Kisilevsky R. The ultrastructural localization of sulfated proteoglycans is identical in the amyloids of Alzheimer's disease and AA, AL, senile cardiac and medullary carcinoma associated amyloidosis. Acta Neuropathol. 78:1989;202-209.
94. Zarow C., Chui H.C., Hsu E., Perlmutter L.S. Correlation between microangiopathy and neuronal loss in Alzheimer's disease. Soc. Neurosci. 15:1989;1376. (Abstr.).